Industry Education Session details

From Detection to Direction: Genomic Testing Strategies in Oncology Research

As genomic testing technologies mature across the oncology research and translational landscape, moving from assay validation to real-world application remains a critical area of focus. This session explores how next-generation sequencing tools are being leveraged in oncology-focused research, from initial validation through translational implementation, offering attendees practical insight into study design, evidence generation, and the path from research findings toward downstream clinical utility.

Wednesday, November 11 | 1:00 PM to 1:50 PM | Chelan 2, Level 2, Arch at 800 Pike

Partner Talk - Next-Generation Sequencing with Roche’s AXELIOS 1 Platform

Join us to learn how Roche’s AXELIOS 1 NGS Platform, powered by sequencing by expansion (SBX) technology, delivers on flexibility, speed, scalability, and high accuracy. By converting DNA into measurable Xpander molecules, SBX achieves high concordant base accuracy (Q38) and read lengths up to 1,500 bp. Its decoupled architecture, which combines automated synthesis, a sequencing instrument with a reusable sensor module (20 runs), and integrated compute, enables near real-time base calling. With tunable run times, flexible batch sizes, and digital management software, it provides a streamlined solution for diverse applications.

Wednesday, November 11 | 12:00 PM to 12:50 PM | Yakima 1, Level 1, Arch at 800 Pike